More than that, accumulating studies suggest that SOX2 acts as an oncogene in some cancers, such as skin squamous-cell carcinoma [29, 30], lung squamous-cell carcinoma [31, 32], ovarian carcinoma [33], osteosarcomas [34] and glioblastoma [35]. This evidence concerns the gene SOX2 and squamous cell lung carcinoma.